» Authors » Marc Goethals

Marc Goethals

Explore the profile of Marc Goethals including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 68
Citations 1331
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Moya A, de Oliveira E, Beles M, Buytaert D, Goethals M, Dierckx R, et al.
Int J Cardiol Heart Vasc . 2025 Feb; 55:101551. PMID: 39911619
Background: Cardiac transthyretin (ATTR) amyloidosis is an often underdiagnosed and potentially fatal disorder associated with poor survival. The National Amyloidosis Centre (NAC) staging system, based on NT-proBNP level and eGFR...
2.
Moya A, de Oliveira E, Delrue L, Beles M, Buytaert D, Goethals M, et al.
Int J Cardiol Heart Vasc . 2024 Aug; 53:101474. PMID: 39156917
Background: Transcatheter aortic valve replacement(TAVR) has shown clear survival benefits in severe aortic valve stenosis(AS). However, patients unable to recover left ventricle function remain at risk with poor long-term survival....
3.
Moya A, Buytaert D, Beles M, Paolisso P, Duchenne J, Huygh G, et al.
J Clin Med . 2023 Feb; 12(4). PMID: 36836187
Serial transthoracic echocardiographic (TTE) assessment of LVEF and GLS are the gold standard in screening Cancer Therapeutics-Related Cardiac Dysfunction (CTRCD). Non-invasive left-ventricle (LV) pressure-strain loop (PSL) emerged as a novel...
4.
Herman R, Vanderheyden M, Vavrik B, Beles M, Palus T, Nelis O, et al.
ESC Heart Fail . 2022 Jun; 9(5):3575-3584. PMID: 35695324
Aims: Risk stratification in patients with a new onset or worsened heart failure (HF) is essential for clinical decision making. We have utilized a novel approach to enrich patient level...
5.
Kobediona M, Bartunek J, Delrue L, Van Durme F, Lau C, Moya A, et al.
Transplant Direct . 2022 Jun; 8(6):e1336. PMID: 35651587
Methods: In 36 HTx, FPs were measured before and after volume load, following which Starling curves were constructed using PCWP and cardiac index (CI). Patients were categorized into those with...
6.
Delrue L, Vanderheyden M, Beles M, Paolisso P, Di Gioia G, Dierckx R, et al.
ESC Heart Fail . 2021 Nov; 8(6):4780-4790. PMID: 34725968
Aims: We investigated the prognostic relevance of serpin peptidase inhibitor, clade A member 3 (SERPINA3) in patients admitted with a de novo or worsened heart failure (HF). Methods And Results:...
7.
Mileva N, Nagumo S, Gallinoro E, Sonck J, Verstreken S, Dierkcx R, et al.
Diagnostics (Basel) . 2021 Oct; 11(10). PMID: 34679451
Cardiac transplant-related vasculopathy remains a leading cause of morbidity and mortality in heart transplant (HTx) recipients. Recently, coronary angiography-derived vessel fractional flow reserve (vFFR) has emerged as a new diagnostic...
8.
Verhestraeten C, Weijers G, Debleu D, Ciarka A, Goethals M, Droogmans S, et al.
PLoS One . 2020 Dec; 15(12):e0244485. PMID: 33382755
Aims: Creation of an algorithm that includes the most important parameters (history, clinical parameters, and anamnesis) that can be linked to heart failure, helping general practitioners in recognizing heart failure...
9.
Nagumo S, Gallinoro E, Candreva A, Mizukami T, Monizzi G, Kodeboina M, et al.
J Interv Cardiol . 2020 Aug; 2020:9835151. PMID: 32733172
Background: Cardiac allograft vasculopathy (CAV) remains the Achilles' heel of long-term survival after heart transplantation (HTx). The severity and extent of CAV is graded with conventional coronary angiography (COR) which...
10.
Heggermont W, Delrue L, Dierickx K, Dierckx R, Verstreken S, Goethals M, et al.
Transplant Direct . 2020 Jun; 6(5):e549. PMID: 32548243
Methods: We studied 39 heart transplant recipients, 21 with proven allograft vasculopathy (CAV+) and 18 without allograft vasculopathy (CAV-) with serial coronary angiograms. Additionally, 8 patients with end-stage native coronary...